Trial Profile
Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with Crohn's disease in active phase.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 27 May 2016
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Sponsors Zeria
- 20 Jan 2012 New trial record